MIC Festival 2019

The MIC Festival of the Medical Imaging Cluster (MIC) of the Medical University of Vienna took place last week on June, 6th 2019. This year’s motto was Digital Revolution in Medical Imaging, highlighting the ever growing importance of big data, digitalization and computational analysis and their translation to clinical routine and research. Just as last […]

New Chelator for Radiolabelling

In a joint research effort supported by the Swiss National Science Foundation, the groups of Prof. Gilles Gasser (Chimie ParisTech) and Prof. Thomas Mindt (LBIAD) have developed a new chelator for the radiolabelling of antibodies and other molecules with the PET radiometal zirconium-89.[1] The new chelator, termed DFO*, provides 89Zr-complexes that are extraordinarily stable in […]

What about industry?

Thomas Dillinger, PhD student of our LBI’s Program Line Molecular Pathology, has spent two months with Boehringer Ingelheim in Vienna to gain insights into the research-driven pharmaceutical industry, to pick up on new laboratory techniques and to establish fruitful connections with new colleagues from various fields of expertise. His stay was funded thanks to a […]

Keio University

Japan – One Year Later

By Loan Tran, PhD student, PL Molecular Pathology, Egger group Internship (05.02.18-30.03.18) at Division of Pharmacotherapeutics, Keio University Faculty of Pharmacy, Tokyo, Japan Founded in 1858, Keio is one of the most prestigious private universities in Japan. Exactly one year ago, I had the honor to join the laboratory of Assoc. Prof. Yoshimasa Saito and […]

Congratulations!

Congratulations to Dr. med. univ. Johannes Längle to the Researcher of the Month Award! Fitting to this month’s Colorectal Cancer Awareness Campaign, the award was bestowed by the Medical University of Vienna on occasion of his recent publication about colorectal liver metastases and the implication of DNA damage with their prognosis and treatment response. The […]

Markus Zeitlinger received several grants

Congratulations to Markus Zeitlinger, head of the Department of Clinical Pharmacology and key researcher of LBI:AD’s program line Clinical Applications. He received several grants for projects within the „AMR Accelerator Program“ of the Innovative Medicine Initiative (IMI). The Initiative supports studies targeting the investigation of multi-drug resistance to antibiotics. Read more >>here<<

Johannes Längle erhielt den Theodor-Billroth-Preis

(Wien, 08-01-2019) Der Theodor-Billroth-Preis der Wiener Ärztekammer ging heuer dreigeteilt mit Johannes Koren und Johannes Längle an zwei Forscher der MedUni Wien sowie an Maximilian Tscharre vom Landesklinikum Wiener Neustadt. Zum Theodor-Billroth-Preis der Ärztekammer für Wien Zur Förderung wissenschaftlicher Arbeiten stiftet die Ärztekammer für Wien den „Theodor-Billroth-Preis der Ärztekammer für Wien”. Der „Theodor-Billroth-Preis” wird alljährlich […]